News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
Musk: A SpaceX-Tesla merger would reshape the AI empire
CoinWorld news, Musk said at Tuesday's earnings conference call that the boards of SpaceX and Tesla have established special committees to study a merger of the two largest companies, which would create an enterprise valued at approximately $3.5 trillion, spanning rockets, electric vehicles, humanoid robots, social networks, and the Grok chatbot. He noted that the merger would share resources such as superintelligence software, chip design, robotics technology, and satellite data centers. Although no agreement has been signed, Musk warned that assuming the merger is certain "would be an exaggeration." He expects the merged company to have a leading AI chatbot, social network, chip factories, and robots, among other things.
SpaceX's better-than-expected results spark debt concerns
According to CoinWorld news, SpaceX's net profit in the third quarter reached $4.4 billion, far exceeding the market expectation of $1.88 billion, with revenue growing 161% year-over-year, driving its stock price up as much as 12.4% intraday on Wednesday. However, the company stated that it will continue to invest heavily, raising market concerns about the expansion of future debt issuance. The spread on SpaceX's bonds maturing in 2046 with a 6.6% coupon widened by 9 basis points to 264 basis points, and the price of five-year credit default swaps (CDS) once rose to 232.6 basis points, hitting new highs multiple times this month. SpaceX Chief Financial Officer Bret Johnsen said the company will focus its investments on computing power for its superintelligence division and its Starlink broadband and mobile businesses, and is in talks with multiple sources of debt capital for financing.
Anthropic may publicly file its S-1 IPO prospectus this Friday.
According to CoinWorld news, Unusual Whales reports that Anthropic may publicly file its S-1 IPO prospectus as early as this Friday. The company's pre-IPO perpetual contracts on the Liquid platform have pushed back to an implied valuation of approximately $2 trillion as the company gradually approaches its anticipated IPO.
Google CEO Pichai: Company sacrificed short-term cloud revenue to prioritize frontier AI
According to CoinWorld news, Google ($GOOGL) CEO Sundar Pichai said the company is sacrificing short-term cloud revenue to prioritize the development of frontier artificial intelligence (AI).
Anthropic appoints physicist Christopher Stubbs to its Long-Term Benefit Trust.
CoinWorld news: Anthropic announced the appointment of physicist Christopher Stubbs to its long-term benefit trust.
The long-short account ratio for ETH contracts is 2.27.
CoinWorld data: The ETHUSDT 4-hour long-short account ratio is 2.27, with more net long accounts than net short accounts. Compared with the same-caliber snapshot 24 hours ago, it is down 0.5264; compared with the same-caliber snapshot 7 days ago, it is down 1.0236.
Canada saw nearly 650,000 P2P crypto transactions per month in spring 2024.
CoinWorld data: According to Cointelegraph, Canada's monthly P2P crypto trading peaked at nearly 650,000 transactions in the spring of 2024 and has since declined along with the issuance of study permits.
pump fun向Kraken转移129.8K枚SOL，价值约1406万美元
CoinWorld data: OnchainLens reports that pump fun transferred 129,800 SOL from its fee wallet to Kraken, worth approximately $14.06 million at current prices, possibly for the purpose of selling.
Aries raises $7 million to launch stock trading platform
Coin World news, fintech startup Aries has recently completed a $7 million seed funding round, led by Thomas Peterffy, with participation from Kleiner Perkins, Collision, John Paulson, and 638 Aries users. The company has launched a stock trading platform built around Aries Infinite, where users can create an infinite trading canvas by building widgets or asking AI. Aries also operates on finance.dev, offering an open API for building your own market tools. In addition, new accounts can receive one free stock worth up to $500, subject to applicable terms.